Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
2.
J Med Genet ; 43(10): e52, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17047092

RESUMEN

BACKGROUND: Compound heterozygotes of the haemochromatosis gene (HFE) variants, H63D and C282Y, have raised transferrin saturation compared with that in the wild type. In the cohort of the Oxford Project To Investigate Memory and Ageing (OPTIMA), bicarriers of the HFE C282Y and the transferrin C2 gene variants are at five times greater risk of developing Alzheimer's disease; the addition of HFE H63D may raise the risk still further. OBJECTIVE: To investigate transferrin saturation by HFE and transferrin genotype among people without dementia-that is, controls and those with mild cognitive impairment (MCI)-and also among those with Alzheimer's disease. METHODS: Serum iron status and genotype were examined of 177 patients with Alzheimer's disease, 69 patients with MCI and 197 controls from the OPTIMA cohort. RESULTS: Although each of these variants alone had relatively little effect on iron status, the combination of either HFE C282Y and HFE H63D or of HFE C282Y and transferrin C2 markedly raised transferrin saturation in those without dementia, but had little effect in those with mature Alzheimer's disease. CONCLUSIONS: These combinations may raise the risk for Alzheimer's disease, owing to higher iron loads and therefore oxidative stress in the preclinical phase. If replicated, these findings will have implications for the prevention of Alzheimer's disease.


Asunto(s)
Enfermedad de Alzheimer/genética , Sobrecarga de Hierro/genética , Hierro/metabolismo , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/epidemiología , Apolipoproteína E4/genética , Estudios de Cohortes , Femenino , Genotipo , Hemocromatosis/epidemiología , Hemocromatosis/genética , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Hierro/sangre , Masculino , Proteínas de la Membrana/genética , Persona de Mediana Edad , Polimorfismo Genético , Factores de Riesgo , Transferrina/metabolismo
3.
J Med Genet ; 41(4): 261-5, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15060098

RESUMEN

BACKGROUND: There is evidence that iron may play a role in the pathology of Alzheimer's disease (AD). There may be genetic factors that contribute to iron deposition resulting in tissue damage thus exacerbating AD. METHODS: We have genotyped 269 healthy elderly controls, 191 cases with definite or probable AD, and 69 with mild cognitive impairment (MCI) from the OPTIMA cohort. RESULTS: We have examined the interaction between the C2 variant of the transferrin (TF) gene and the C282Y allele of the haemochromatosis (HFE) gene as risk factors for developing AD. Our results showed that each of the two variants was associated with an increased risk of AD only in the presence of the other. Neither allele alone had any effect. Carriers of both variants were at 5 times greater risk of AD compared with all others. The interaction was significant by logistic regression (p = 0.014) and by synergy factor analysis (p = 0.015, synergy factor = 5.1). Further, carriers of these two alleles plus apolipoprotein E epsilon4 (APOE4) were at still higher risk of AD: of the 14 tri-carriers of the three variants, identified in this study, 12 had AD and two MCI. CONCLUSION: We suggest that the combination of TF C2 and HFE C282Y may lead to an excess of redox-active iron and the induction of oxidative stress in neurones, which is exacerbated in carriers of APOE4. Since 4% of Northern Europeans carry the two iron-related variants and since iron overload is a treatable condition, these results merit replication.


Asunto(s)
Alelos , Enfermedad de Alzheimer/genética , Predisposición Genética a la Enfermedad , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana/genética , Transferrina/genética , Anciano , Enfermedad de Alzheimer/metabolismo , Apolipoproteína E4 , Apolipoproteínas E/genética , Estudios de Casos y Controles , Trastornos del Conocimiento/genética , Femenino , Genotipo , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/metabolismo , Humanos , Hierro/metabolismo , Masculino , Proteínas de la Membrana/metabolismo , Estrés Oxidativo , Polimorfismo Genético , Transferrina/metabolismo
4.
J Med Genet ; 41(10): 721-30, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15466004

RESUMEN

Mutations in the hepcidin gene HAMP and the hemojuvelin gene HJV have recently been shown to result in juvenile haemochromatosis (JH). Hepcidin is an antimicrobial peptide that plays a key role in regulating intestinal iron absorption. Hepcidin levels are reduced in patients with haemochromatosis due to mutations in the HFE and HJV genes. Digenic inheritance of mutations in HFE and HAMP can result in either JH or hereditary haemochromatosis (HH) depending upon the severity of the mutation in HAMP. Here we review these findings and discuss how understanding the different types of haemochromatosis and our increasing knowledge of iron metabolism may help to elucidate the host's response to infection.


Asunto(s)
Hemocromatosis/genética , Hemocromatosis/metabolismo , Pruebas Genéticas , Hemocromatosis/complicaciones , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Infecciones/complicaciones , Infecciones/genética , Infecciones/metabolismo , Sobrecarga de Hierro/complicaciones , Sobrecarga de Hierro/genética , Sobrecarga de Hierro/metabolismo , Proteínas de la Membrana/genética
5.
J Med Genet ; 41(1): 6-10, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14729817

RESUMEN

BACKGROUND: Patients with hereditary haemochromatosis (HH) are usually homozygous for the C282Y mutation in the HFE gene. They have variable expression of iron overload and present with a variety of complications, including liver disease, diabetes, arthropathy, fatigue, and cardiomyopathy. The mitochondrial 16189 variant is associated with diabetes, dilated cardiomyopathy, and low body fat at birth, and might contribute to genetic predisposition in further multifactorial disorders. The objective of this study was to determine the frequency of the 16189 variant in a range of patients with haemochromatosis, who had mutations in the HFE gene. METHODS: Blood DNA was analysed for the presence of the 16189 variant in British, French, and Australian C282Y homozygotes and controls, with known iron status, and in birth cohorts. RESULTS: The frequency of the mitochondrial 16189 variant was found to be elevated in individuals with haemochromatosis who were homozygous for the C282Y allele, compared with population controls and with C282Y homozygotes who were asymptomatic (42/292 (14.4%); 102/1186 (8.6%) (p = 0.003); and 2/64 (3.1%) (p = 0.023), respectively). CONCLUSIONS: Iron loading in C282Y homozygotes with HH was exacerbated by the presence of the mitochondrial 16189 variant.


Asunto(s)
Sustitución de Aminoácidos/genética , ADN Mitocondrial/genética , Hemocromatosis/genética , Homocigoto , Mutación/genética , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Cisteína/genética , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/patología , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/patología , Frecuencia de los Genes/genética , Genotipo , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Sobrecarga de Hierro/genética , Proteínas de la Membrana/genética , Persona de Mediana Edad , Fenotipo , Tirosina/genética
6.
Genet Test ; 4(2): 115-20, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10953949

RESUMEN

The gene for hemochromatosis was identified in 1996 and two mutations were found. Homozygosity for one of these, C282Y, is associated with hemochromatosis in a high percentage of patients. Genetic analysis of patient DNA is, therefore, a very useful tool to aid and confirm diagnosis and to screen asymptomatic relatives of patients to identify those at risk of developing this common, easily treated disease.


Asunto(s)
Antígenos HLA/genética , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana , Mutación , Cartilla de ADN , Hemocromatosis/genética , Proteína de la Hemocromatosis , Humanos , Ácidos Nucleicos Heterodúplex , Reacción en Cadena de la Polimerasa/métodos , Polimorfismo de Longitud del Fragmento de Restricción , Polimorfismo Conformacional Retorcido-Simple
7.
Genet Test ; 4(2): 151-61, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10953955

RESUMEN

Hereditary hemochromatosis (HH) is a common autosomal recessive disorder of iron metabolism. Iron absorption from the gut is inappropriately high, resulting in increasing iron overload. The hemochromatosis gene (HFE) was identified in 1996 by extensive positional cloning by many groups over a period of about 20 years. Two missense mutations were identified. Homozygosity for one of these, a substitution of a tyrosine for a conserved cysteine (C282Y), has now clearly been shown to be associated with HH in 60-100% of patients. The role of the second mutation, the substitution of an aspartic acid for a histidine (H63D), is not so clear but compound heterozygotes for both these mutations have a significant risk of developing HH. Here we review other putative mutations in the HFE gene and document a number of diallelic polymorphisms in HFE introns.


Asunto(s)
Antígenos HLA/genética , Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana , Mutación , Polimorfismo Genético , Sustitución de Aminoácidos , Exones , Proteína de la Hemocromatosis , Heterocigoto , Homocigoto , Humanos , Intrones
8.
Genet Test ; 4(2): 183-98, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10953959

RESUMEN

Hereditary hemochromatosis (HH) is a common autosomal recessive disorder causing inappropriate dietary iron absorption that affects North Europeans. HH is associated with the C282Y mutation of the HFE gene, and the H63D mutation to a lesser degree. Both mutations are abundant in Europe, with H63D also appearing in North Africa, the Middle East, and Asia. Emigration from Europe over the past 500 years has introduced C282Y and H63D to America, Australia, New Zealand, and South Africa in an essentially predictable fashion. The distinctive characteristics of the population genetics of HH are the confined racial distribution and high frequency in North European peoples. C282Y frequencies in North Europeans are typically between 5% and 10%, with homozygotes accounting for between 1/100 and 1/400 of these populations. The scarcity of the C282Y mutation in other populations accounts for the lack of HH in non-Europeans.


Asunto(s)
Antígenos HLA/genética , Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana , Mutación , Emigración e Inmigración , Genética de Población , Geografía , Hemocromatosis/etnología , Proteína de la Hemocromatosis , Humanos
9.
Acta Virol ; 38(6): 311-5, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7793354

RESUMEN

Trichoplusia ni larvae have been injected with a mixture of wild-type Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) and a mutant derivative, AcRP8.UW1.lacZ, which lacks the polyhedrin gene, and has the p10 gene replaced by the Escherichia coli beta-galactosidase gene. Following plaque assay of the haemolymph and subsequent staining for beta-galactosidase activity and scoring for polyhedra, recombinant plaques were identified and the recombination frequency estimated as 6.6%.


Asunto(s)
Nucleopoliedrovirus/genética , Recombinación Genética , Animales , Escherichia coli/genética , Larva , Mariposas Nocturnas , Mutación , Proteínas de la Matriz de Cuerpos de Oclusión , Proteínas Virales/genética , Proteínas Estructurales Virales , beta-Galactosidasa/genética
10.
J Med Genet ; 34(4): 275-8, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9138148

RESUMEN

Haemochromatosis is a genetic disease associated with progressive iron overload, and is common among populations of northern European origin. HLA-H is a recently reported candidate gene for this condition. Two mutations have been identified, a substitution of cysteine for tyrosine at amino acid 282 (C282Y, nucleotide 845) and of histidine for aspartate at amino acid 63 (H63D, nucleotide 187). Over 90% of UK haemochromatosis patients are homozygous for the C282Y mutation. We have examined 5956 chromosomes (2978 people) for the presence of HLA-H C282Y and H63D by PCR followed by restriction enzyme analysis. We have found world wide allele frequencies of 1.9% for C282Y and 8.1% for H63D. The highest frequencies were 10% for C282Y in 90 Irish chromosomes and 30.4% for H63D in 56 Basque chromosomes. C282Y was most frequent in northern European populations and absent from 1042 African chromosomes, 484 Asian chromosomes, and 644 Australasian chromosomes. The distribution of the C282Y mutation coincides with that of populations in which haemochromatosis has been reported and is consistent with the theory of a north European origin for the mutation. The H63D polymorphism is more widely distributed and its connection with haemochromatosis remains unclear.


Asunto(s)
Frecuencia de los Genes , Hemocromatosis/genética , Proteínas de la Membrana , Mutación , Alelos , Antígenos HLA/genética , Hemocromatosis/epidemiología , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Polimorfismo de Longitud del Fragmento de Restricción
11.
J Gastroenterol Hepatol ; 14(9): 838-43, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10535463

RESUMEN

Mutations in the haemochromatosis (HFE) gene cause most of the cases of hereditary haemochromatosis among people of Northern European ancestry while remaining a rare cause of iron overload among indigenous persons of the Asia-Pacific region. Advances in understanding of the role of the HFE protein product and other recently cloned iron transporters signify an exciting period, as previously unknown components of the iron metabolism pathway are revealed one by one. Epidemiological studies have shown that this gene is more widespread than its phenotypic expression would suggest and that the heterozygous state may be implicated in the expression of other diseases of the liver such as porphyria cutanea tarda, hepatitis C virus infection and non-alcoholic steatohepatitis. The diagnosis, management and ethical implications for clinical practice in the aftermath of this discovery are discussed.


Asunto(s)
Genes MHC Clase I , Antígenos HLA/genética , Hemocromatosis/epidemiología , Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana , Asia/epidemiología , Pueblo Asiatico/genética , Europa (Continente)/epidemiología , Pruebas Genéticas , Salud Global , Hemocromatosis/diagnóstico , Hemocromatosis/etnología , Proteína de la Hemocromatosis , Humanos , Hierro/metabolismo , Sobrecarga de Hierro/genética , Mutación , Vigilancia de la Población , Población Blanca/genética
12.
Br J Haematol ; 99(2): 460-3, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9375773

RESUMEN

We describe the rapid single-step detection, by mutagenically separated polymerase chain reaction (MS-PCR), of the HLE C282Y mutation, for which > 90% of haemochromatosis patients in the U.K. are homozygous. In addition to using purified DNA as a template, whole blood and lysed buccal cell extracts from mouthwash samples can be used. Therefore sample collection may be non-invasive and purification steps kept to a minimum.


Asunto(s)
Hemocromatosis/genética , Mutación , Técnicas Genéticas , Hemocromatosis/diagnóstico , Humanos , Antisépticos Bucales , Reacción en Cadena de la Polimerasa
13.
Hum Mutat ; 13(2): 154-9, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10094552

RESUMEN

We have retrospectively analyzed 837 random anonymized dried blood spot (DBS) samples from neonatal screening programs in Scandinavia for mutations in HFE, the candidate gene for hemochromatosis. We have found C282Y allele frequencies of 2.3% (+2.0%) (-1.3%) in Greenland, 4.5%+/-1.9% in Iceland, 5.1%+/-2.3% in the Faeroe Islands, and 8.2%+/-2.7% in Denmark. The high prevalence of HFE mutations in Denmark suggests that population screening for the C282Y mutation could be highly advantageous in terms of preventive health care. Long-term follow-up evaluation of C282Y homozygotes and H63D/C282Y compound heterozygotes will give an indication of the penetrance of the mutations.


Asunto(s)
Pruebas Genéticas , Antígenos HLA/genética , Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana , Mutación/genética , Tamizaje Neonatal , Alelos , Genes MHC Clase I/genética , Hemocromatosis/epidemiología , Proteína de la Hemocromatosis , Humanos , Recién Nacido , Proyectos Piloto , Estudios Retrospectivos , Países Escandinavos y Nórdicos/epidemiología
14.
Br J Haematol ; 101(2): 369-73, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9609537

RESUMEN

High frequencies of the haemochromatosis-related HFE C282Y mutation have been reported in North European populations, in which a high proportion of patients with the disease are homozygotes. However, the degree of penetrance of this genotype is unknown. We determined the HFE C282Y and H63D genotypes of 411 consenting volunteer blood donors on Jersey, and the serum ferritin and transferrin saturation levels of 204 of these volunteers. The C282Y allele frequency was found to be 8.3% in 822 chromosomes, indicating a homozygote frequency of 1/145. Consistent with this, four C282Y homozygotes were detected in 411 volunteers. As there are only 18 patients presently receiving treatment for haemochromatosis on Jersey, out of a total population of about 85000, there is a large discrepancy between the number of haemochromatosis patients and the number of C282Y homozygotes in this population. In a preliminary study of 204 consenting volunteers we found a correlation between transferrin saturation and HFE H63D/ C282Y genotype (P=0.017) and between serum ferritin and genotype (P = 0.056). We also observed elevated values of transferrin saturation in the two C282Y homozygotes assayed. These results suggest that a large proportion of the many undetected C282Y homozygotes on Jersey and in similar populations could be in the preclinical stages of haemochromatosis, and warrant investigation. However, there may be a wide variation in the expression of the condition, and a more extensive study of the level of disease penetrance encompassing a large number of hitherto undetected C282Y homozygotes is therefore imperative.


Asunto(s)
Ferritinas/sangre , Hemocromatosis/genética , Mutación , Penetrancia , Transferrina/análisis , Adulto , Islas Anglonormandas/epidemiología , Femenino , Genotipo , Hemocromatosis/sangre , Hemocromatosis/epidemiología , Homocigoto , Humanos , Masculino
15.
Mamm Genome ; 9(3): 220-5, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9501306

RESUMEN

We have generated a detailed physical map of the 6p21.3/p22.1 boundary, using a combination of yeast artificial chromosome (YAC) fragmentation and high-resolution sequence tagged site (STS) content mapping. YACs from the CEPH, St. Louis, and ICRF libraries have been used to construct a 4.5-Mb contig spanning the markers D6S306 to D6S1571. YAC insert sizes were determined by pulsed field gel electrophoresis (PFGE). Chimerism of YACs was determined by fluorescent in situ hybridization (FISH), and their integrity was determined by fingerprinting with Alu-PCR. We have identified 10 new CA repeat loci in this region as well as over 50 novel STSs, several tRNA genes, a new histone H2B gene and the phospholipase D gene. Using these new markers, we have rapidly generated a bacterial clone contig of over 250 kb, spanning the markers D6S1260 to D6S1918 (WI-3111) with STSs spaced on average every 6 kb.


Asunto(s)
Mapeo Cromosómico , Cromosomas Artificiales de Levadura , Hibridación Fluorescente in Situ/métodos , Lugares Marcados de Secuencia , Animales , Secuencia de Bases , Cromosomas Bacterianos , Marcadores Genéticos , Histonas/genética , Humanos , Ratones , Datos de Secuencia Molecular , ARN de Transferencia de Serina , ARN de Transferencia de Valina
16.
J Intern Med ; 253(2): 217-24, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12542563

RESUMEN

OBJECTIVE: To determine the optimal means of identifying patients with undiagnosed haemochromatosis. DESIGN: Case-control study where cases are defined by the presence of specific clinical diagnoses or symptoms. SETTING: Primary care patients were recruited from three Oxfordshire practices and secondary care patients were recruited from those patients attending specialist clinics in Amiens University Hospital. SUBJECTS: A total of 569 patients recruited via hospital clinics and 60 primary care patients (recruited from 4022 consultations) presenting with the following haemochromatosis associated conditions, diabetes, arthralgia/chronic fatigue, osteoporosis or arthropathy were studied. The control group, a total of 991 healthy volunteers, were recruited through a Health Appraisal Centre. Patients and controls were included in the study if they or their family members had not previously been diagnosed with hereditary haemochromatosis. MAIN OUTCOME MEASURES: Serum ferritin concentration, transferrin saturation (Tsat) and presence of HFE mutations, C282Y and H63D. The check-up in controls consisted of a questionnaire, clinical examination, biochemical tests and screening for the presence of the C282Y and H63D mutations. RESULTS: Patient groups presenting with unstable diabetes or chronic fatigue and arthralgia together with a raised serum ferritin concentration showed an enrichment in the haemochromatosis-associated genotype HH/YY, odds ratio (OR) = 40.1, confidence interval (CI) = 8.0-202.1 and OR = 103, CI = 22.9-469.7, respectively. CONCLUSION: Patients presenting to hospital clinics with haemochromatosis associated conditions should be screened biochemically for iron overload. Only those with a serum ferritin >300 microg L-1 or Tsat >40% should subsequently go on to be genotyped for HFE mutations. The patients at greatest risk of having undiagnosed haemochromatosis are those presenting with unstable diabetes, or fatigue and/or arthralgia in the absence of any other explanation.


Asunto(s)
Hemocromatosis/diagnóstico , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana/genética , Mutación/genética , Adulto , Anciano , Estudios de Casos y Controles , Femenino , Ferritinas/sangre , Hemocromatosis/genética , Proteína de la Hemocromatosis , Heterocigoto , Homocigoto , Humanos , Masculino , Persona de Mediana Edad , Transferrina/análisis
17.
Am J Hum Genet ; 64(4): 1056-62, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10090890

RESUMEN

Genetic hemochromatosis (GH) is believed to be a disease restricted to those of European ancestry. In northwestern Europe, >80% of GH patients are homozygous for one mutation, the substitution of tyrosine for cysteine at position 282 (C282Y) in the unprocessed protein. In a proportion of GH patients, two mutations are present, C282Y and H63D. The clinical significance of this second mutation is such that it appears to predispose 1%-2% of compound heterozygotes to expression of the disease. The distribution of the two mutations differ, C282Y being limited to those of northwestern European ancestry and H63D being found at allele frequencies>5%, in Europe, in countries bordering the Mediterranean, in the Middle East, and in the Indian subcontinent. The C282Y mutation occurs on a haplotype that extends

Asunto(s)
Pruebas Genéticas , Antígenos HLA/genética , Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana , Mutación/genética , Alelos , Sustitución de Aminoácidos/genética , Asia Sudoriental/etnología , Femenino , Francia , Frecuencia de los Genes/genética , Genotipo , Haplotipos/genética , Proteína de la Hemocromatosis , Humanos , Masculino , Mianmar/etnología , Linaje , Filogenia , Polimorfismo Genético/genética , Selección Genética , Sri Lanka
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA